Tablet case
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
FIG. 1 is a perspective view, as viewed from the front left, of a tablet case showing my new design;
FIG. 2 is a top plan view thereof;
FIG. 3 is a rear elevational view thereof;
FIG. 4 is a left side view thereof, the right side elevational view being identical thereto;
FIG. 5 is a bottom plan view thereof;
FIG. 6 is a front elevational view of an insert of FIG. 1 thereof; shown separately for clarity of illustration;
FIG. 7 is a left side elevational view of FIG. 6; the right side elevational view being identical thereto;
FIG. 8 is a top plan view of FIG. 6;
FIG. 9 is a front elevational view of FIG. 6; shown in completely open position;
FIG. 10 is a left side elevational view of FIG. 9; the right side elevational view being identical thereto;
FIG. 11 is a rear elevational view of FIG. 9; and,
FIG. 12 is a top plan view of FIG. 9; the bottom plan view being identical thereto.
Type: Grant
Filed: Aug 12, 1991
Date of Patent: Jul 6, 1993
Assignee: Glaxo Group Limited (London)
Inventor: Gregor John M. Anderson (Bengeo)
Primary Examiner: Bernard Ansher
Assistant Examiner: Prabhakar Deshmuhk
Law Firm: Darby & Darby
Application Number: 7/744,011